Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D003024:Clozapine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism; D003984:Dibenzazepines / Q000494:pharmacology*; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005476:Fluphenazine / Q000494:pharmacology*; D006624:Hippocampus / Q000378:metabolism; D008297:Male; D051379:Mice; D010862:Pilocarpine / Q000494:pharmacology; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000378:metabolism*; D011976:Receptors, Muscarinic / Q000378:metabolism*
D003984:Dibenzazepines; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D010862:Pilocarpine; D011813:Quinuclidinyl Benzilate; D002795:Choline O-Acetyltransferase; D003024:Clozapine; D005476:Fluphenazine